- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2022–2027 · cooperative agreement · U24
Generating a full-length reference transcriptome for human protein-coding genes
David E. Hill · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2024 · grant · PCRP
Integrative Analysis of Prostate-Specific Membrane Antigen and Amino Acid Transporter Cistromes for Precision Molecular Imaging of Metastatic Prostate Cancer
Mohamadreza Bakht · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2025 · grant · OCRP
An Implantable Microdevice for Efficient In Vivo Testing of Targeted Therapies in Ovarian Clear Cell Cancer
Elizabeth Stover · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2024 · research · R21
STEP-YA: An Online Self-Management Intervention for Young Adult Cancer Survivors with Insomnia
Christopher John Recklitis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · career development · K08
Diversifying Acute Leukemia Clinical Trial Enrollment Through Multilevel Intervention
Andrew Hantel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Generating a full-length reference transcriptome for human protein-coding genes
David E. Hill · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
Toni Choueiri · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2025 · award
Improving immunological memory during anti-PD-1 immunotherapy
Arlene Sharpe · Dana-Farber Cancer Institute · funded by Melanoma Research Alliance
2022–2023 · career development · K99
Mechanistic Understanding of Hypoxia-Induced Peroxisome loss: Implications for Heart Failure
Greg Wyant · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
Andrew James Aguirre · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2025 · career development · K00
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
Camila Robles-Oteiza · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
Andrew James Aguirre · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · career development · K00
Targeting Oncogenic Drivers in Cancer
Matthew W Boudreau · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Cell lineage as an indicator of immune response in neuroblastoma
Rani E. George · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · grant · MRP
Defective Tumor Mitochondria Drives Intrinsic Immunogenicity Through MHC Class 1 Antigen Presentation and T-Cell Engagement
Pere Puigserver · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2024 · grant · PCRP
Harnessing Neighborhood Factors to Improve Targeting of Early Detection Programs for Men with Prostate Cancer
Charlotte Roscoe · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2024 · career development · K99
SESORRS endoscopy for the staging and evaluation of colorectal cancer
Fay Nicolson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · grant · KCRP
Circulating Biomarkers in Renal Cell Carcinoma
Wenxin Xu · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2026 · research · R01
Genomic Diversity of Prostate Cancer Across the African Diaspora
Timothy R Rebbeck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2024 · research · R03
Repurposing Bruton's tyrosine kinase (BTK) inhibitors to reverse immunosuppression in high-grade serous ovarian cancer (HGSC)
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2024 · fellowship · F32
Elucidating novel molecular mechanisms of irisin-mediated effects via integrin
Mu A · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Defining the landscape and mechanisms of protein redox regulation during aging
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · career development · K08
Novel targeted therapies for chronic myelomonocytic leukemia
Roger Vincent Belizaire · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Selective disruption of histone deacetylase complexes using protein interaction modulators
Marc Vidal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R50
Molecular origins and evolution to treatment resistance in genitourinary cancers
Jihye Park · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · grant · KCRP
Dissecting Germline Genetic Mediators of Clinical Response to Immune Checkpoint Blockade in Kidney Cancer
Saud Aldubayan · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2029 · research · R35
Molecular Prediction of Myeloma Initiation Molecular Prediction of Myeloma Initiation
Irene M. Ghobrial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · program · P50
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
David A Barbie · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2025 · research · R21
Sleep Treatment Education Program-1 (STEP-1): A Randomized Trial of a Self-Management Insomnia Intervention for Cancer Survivors
Christopher John Recklitis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Synthetic lethalities to cell cycle disruption in glioma
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2025 · career development · K00
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
Camila Robles-Oteiza · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2024 · research · R21
Translation initiation as a therapeutic target in neuroblastoma
Rani E. George · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · career development · K08
Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancer
William A Freed-Pastor · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022 · research · PCF Challenge Award
Debunking the Frailty-SarcopenIa-ADT Axis in MEtastatic Prostate CanceR with MultiCompenent Exercise: The FIERCE Trial
Christina Dieli-Conwright · Dana-Farber Cancer Institute · funded by Prostate Cancer Foundation
2022 · research · PCF Challenge Award
Developing and Translating Innovative Strategies to Therapeutically Target Prostate Cancer Lineage Plasticity
David Goodrich · Dana-Farber Cancer Institute · funded by Prostate Cancer Foundation
2022 · research · PCF Young Investigator Award
Exercise for Tumor Suppressive Impact in Black Patients with Prostate Cancer on Active Surveillance: The RE-MOVE Trial
Dong-Woo Kang · Dana-Farber Cancer Institute · funded by Prostate Cancer Foundation
2022 · fellowship · AACR-Merck Immuno-oncology Research Fellowship
Targeting CDK4/6 and immune checkpoint to reduce liver cancer disparities
Deyang Yu · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2022 · research · Victoria’s Secret Global Fund for Women’s Cancers Rising Innovator Research Grant, in Partnership with Pelotonia & AACR
Targeting Wee1 and ATR in high-grade/p53-mutated endometrial cancer
Joyce Liu · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
